BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2481357)

  • 1. [Endocrinologic factors in the development of benign prostatic hyperplasia].
    Schweikert HU; Neumann F; Tunn UW
    Urologe A; 1989 Nov; 28(6):317-20. PubMed ID: 2481357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of tissue steroids in benign hyperplasia and prostate cancer].
    Voigt KD; Bartsch W
    Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common characteristics of human and canine benign prostatic hyperplasia.
    Isaacs JT
    Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
    [No Abstract]   [Full Text] [Related]  

  • 4. Human benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens].
    Solè-Balcells F
    J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia: a stromal disease].
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
    Urologe A; 1989 Nov; 28(6):321-8. PubMed ID: 2481358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia in the nonhuman primate.
    Lewis RW
    Prog Clin Biol Res; 1984; 145():235-55. PubMed ID: 6201877
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormones and/or growth factors in prostate hypertrophy, pathophysiology and treatment.
    Mathé G
    Biomed Pharmacother; 1995; 49(7-8):317-8. PubMed ID: 8562855
    [No Abstract]   [Full Text] [Related]  

  • 11. Etiology of benign prostatic hyperplasia.
    Lee C; Kozlowski JM; Grayhack JT
    Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in the ageing male: what about the prostate?
    Schultheiss D; Machtens S; Jonas U
    Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia. Hormonal treatment.
    McConnell JD
    Urol Clin North Am; 1995 May; 22(2):387-400. PubMed ID: 7539183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of androgen action.
    Wilson JD
    Clin Res; 1987 Jan; 35(1):1-12. PubMed ID: 2434280
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
    Scarano WR; Vilamaior PS; Taboga SR
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
    Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
    Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
    Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.